Somatuline Depot (Ipsen Biopharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Somatuline Depot drug offered from Ipsen Biopharmaceuticals, Inc.. This Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Ipsen Biopharmaceuticals, Inc.
NON-PROPRIETARY NAME: lanreotide acetate
SUBSTANCE NAME: LANREOTIDE ACETATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2007-11-14
END MARKETING DATE: 0000-00-00


Somatuline Depot HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSomatuline Depot from Ipsen Biopharmaceuticals, Inc.
LABELER NAME: Ipsen Biopharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 60(mg/.2mL)
START MARKETING DATE: 2007-11-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 15054-0060_b6a04de9-7836-4ccd-9c34-43ffd7ae403b
PRODUCT NDC: 15054-0060
APPLICATION NUMBER: NDA022074

Other LANREOTIDE ACETATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Ipsen Biopharmaceuticals, Inc.Somatuline Depot